Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation

Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis

(2021) Rika Kawakami et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Distinctive Under-Expression Profile of Inflammatory and Redox Genes in the Blood of Elderly Patients with Cardiovascular Disease

(2021) Elena Milanesi et al.   Journal of Inflammation Research

Nrf2 deficiency aggravates PM2.5-induced cardiomyopathy by enhancing oxidative stress, fibrosis and inflammation via RIPK3-regulated mitochondrial disorder

(2020) Chenxu Ge et al.   Aging-US

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome

(2020) Nicholas S. Hendren et al.   CIRCULATION

The Variety of Cardiovascular Presentations of COVID-19

(2020) Justin A. Fried et al.   CIRCULATION

BML‐111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis

(2020) Rafael I. Jaén et al.   FASEB JOURNAL

Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management?

(2020) Tharindu L. Suraweera et al.   Antioxidants

NRF2 in Cardiovascular Diseases: a Ray of Hope!

(2020) Ruju Vashi et al.   Journal of Cardiovascular Translational Research

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation

(2020) Gyeoung Jin Kang et al.   Antioxidants

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

(2019) Antonio Cuadrado et al.   NATURE REVIEWS DRUG DISCOVERY

Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases

(2019) Rafael M. da Costa et al.   Frontiers in Pharmacology

STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

(2018) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Role of NOD1 in Heart Failure Progression via Regulation of Ca 2+ Handling

(2017) Almudena Val-Blasco et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Resveratrol protects against lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization

(2016) Tao Bai et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

(2016) Barry Greenberg et al.   LANCET

Left ventricular diastolic dysfunction in Nrf2 knock out mice is associated with cardiac hypertrophy, decreased expression of SERCA2a, and preserved endothelial function

(2015) Ralf Erkens et al.   FREE RADICAL BIOLOGY AND MEDICINE

The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective

(2015) Carl Hayward et al.   HUMAN GENE THERAPY

Diagnosis of myocarditis: Current state and future perspectives

(2015) P. Stefan Biesbroek et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Reconciling depressed Ca2+sparks occurrence with enhanced RyR2 activity in failing mice cardiomyocytes

(2015) Gema Ruiz-Hurtado et al.   JOURNAL OF GENERAL PHYSIOLOGY

Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function

(2015) Vasundhara Kain et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability

(2014) Marcelo H. Petri et al.   CARDIOVASCULAR RESEARCH

Inhibition of miR-25 improves cardiac contractility in the failing heart

(2014) Christine Wahlquist et al.   NATURE

Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure

(2013) Krisztina Zsebo et al.   CIRCULATION RESEARCH

Update on Myocarditis

(2012) Ingrid Kindermann et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress

(2009) Jinqing Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Increased Ca 2+ Sensitivity of the Ryanodine Receptor Mutant RyR2 R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia

(2008) María Fernández-Velasco et al.   CIRCULATION RESEARCH

Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals

(2008) M J Byrne et al.   GENE THERAPY